title: Effects of colestipol-niacin therapy on human femoral atherosclerosis.
abstract: The 2-year therapy effect on femoral atherosclerosis was evaluated in the Cholesterol Lowering Atherosclerosis Study (CLAS), a randomized, placebo-plus-diet-controlled angiographic trial of colestipol-niacin therapy plus diet in men with previous coronary bypass surgery. Different diet compositions were prescribed to enhance the differential in blood cholesterol responses between the two groups. The annual rate of change in computer-estimated atherosclerosis (CEA), a measure of lumen abnormality, was evaluated between treatment groups. A significant per-segment therapy effect was found in segments with moderately severe atherosclerosis (p less than 0.04) and in proximal segments (p less than 0.02). When segmental CEA measures were combined into a per-patient score using an adaptation of the National Heart, Lung, and Blood Institute scoring procedure, a significant therapy effect was observed (p less than 0.02). Total variance of the annual change rate in CEA was as predicted from pilot studies, but measurement variation was larger. The therapy effect observed in femoral arteries, although significant, was less marked than the strong and consistent benefit previously reported for both native coronary arteries and aortocoronary bypass grafts.
authors.affiliation: Department of Medicine, University of Southern California, Los Angeles 90033.
authors.forename: D H
authors.initials: DH
authors.lastname: Blankenhorn
authors.forename: S P
authors.initials: SP
authors.lastname: Azen
authors.forename: D W
authors.initials: DW
authors.lastname: Crawford
authors.forename: S A
authors.initials: SA
authors.lastname: Nessim
authors.forename: M E
authors.initials: ME
authors.lastname: Sanmarco
authors.forename: R H
authors.initials: RH
authors.lastname: Selzer
authors.forename: A M
authors.initials: AM
authors.lastname: Shircore
authors.forename: E C
authors.initials: EC
authors.lastname: Wickham
mesh_terms: D001161:Arteriosclerosis / Q000628:therapy*; D002791:Cholesterol, Dietary / Q000008:administration & dosage*; D008078:Cholesterol, LDL / Q000097:blood; D003084:Colestipol / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D001026:Coronary Artery Bypass; D005263:Femoral Artery / Q000000981:diagnostic imaging*; D006801:Humans; D007090:Image Interpretation, Computer-Assisted; D008297:Male; D008875:Middle Aged; D009525:Niacin / Q000627:therapeutic use*; D011859:Radiography
chemical_list: D002791:Cholesterol, Dietary; D008078:Cholesterol, LDL; D009525:Niacin; D003084:Colestipol